130 related articles for article (PubMed ID: 2840187)
41. CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non-small cell lung cancer.
Lai RS; Hsu HK; Lu JY; Ger LP; Lai NS
Chest; 1996 Apr; 109(4):995-1000. PubMed ID: 8635383
[TBL] [Abstract][Full Text] [Related]
42. [The diagnostic value of the tumor markers CEA, "Ca 19-9", "Ca 125", "Ca15-3" and "SCC" for the detection of recurrent tumors in patients with tumors of the head and neck].
Zöller J; Fiehn W; Mende U; Hotz G
Dtsch Z Mund Kiefer Gesichtschir; 1990; 14(4):254-9. PubMed ID: 2134649
[TBL] [Abstract][Full Text] [Related]
43. Expression of cancer/testis (CT) antigens in squamous cell carcinoma of the head and neck: evaluation as markers of squamous dysplasia.
Piotti KC; Scognamiglio T; Chiu R; Chen YT
Pathol Res Pract; 2013 Nov; 209(11):721-6. PubMed ID: 24011616
[TBL] [Abstract][Full Text] [Related]
44. [Clinical evaluation of tumor markers in head and neck squamous cell carcinomas].
Yoneda K; Hirota J; Yamamoto T; Ueta E; Osaki T
Gan No Rinsho; 1990 Mar; 36(4):458-64. PubMed ID: 2181163
[TBL] [Abstract][Full Text] [Related]
45. Tumor associated antigen with pulmonary neoplasms.
Lo Gerfo P; Herter FP; Braun J; Hansen HJ
Ann Surg; 1972 Apr; 175(4):495-500. PubMed ID: 4336486
[No Abstract] [Full Text] [Related]
46. Tumor antigen TA-4: an aid in detecting post-operative recurrences of esophageal carcinoma.
Sugimachi K; Kitamura M; Matsuda H; Okudaira Y
Dis Markers; 1987 Jun; 5(2):67-73. PubMed ID: 3502985
[TBL] [Abstract][Full Text] [Related]
47. [Relevance of the new tumor marker SCC (squamous cell carcinoma antigen) for the diagnosis and follow-up control of squamous epithelial carcinoma of the head and neck].
Koch T; Eiffert H; Spindler MB
HNO; 1989 Nov; 37(11):454-9. PubMed ID: 2584067
[TBL] [Abstract][Full Text] [Related]
48. Squamous cell carcinoma of the colon with an elevated serum squamous cell carcinoma antigen responding to combination chemotherapy.
Copur S; Ledakis P; Novinski D; Mleczko KL; Frankforter S; Bolton M; Fruehling RM; VanWie E; Norvell M; Muhvic J
Clin Colorectal Cancer; 2001 May; 1(1):55-8. PubMed ID: 12445380
[TBL] [Abstract][Full Text] [Related]
49. Serum levels of squamous cell carcinoma antigen and ovarian carcinoma antigen (CA 125) in patients with benign and malignant diseases of the uterine cervix.
Gocze PM; Vahrson HW; Freeman DA
Oncology; 1994; 51(5):430-4. PubMed ID: 8052484
[TBL] [Abstract][Full Text] [Related]
50. [Diagnosis of recurrences of head and neck carcinoma with the tumor marker SSC-antigen].
Arlt A; Luckhaupt H; Hildmann H
Laryngorhinootologie; 2000 Apr; 79(4):207-12. PubMed ID: 10838684
[TBL] [Abstract][Full Text] [Related]
51. Squamous cell carcinoma (SCC) antigen in patients with invasive cervical carcinoma during primary irradiation.
Neunteufel W; Tatra G; Bieglmayer C
Gynecol Obstet Invest; 1990; 29(2):154-7. PubMed ID: 2335313
[TBL] [Abstract][Full Text] [Related]
52. [SCC (squamous cell carcinoma) antigen as a tumor marker in cervix cancers].
Geyer H; Schwörer D; Pfleiderer A
Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):266-71. PubMed ID: 2721888
[TBL] [Abstract][Full Text] [Related]
53. Serum squamous cell carcinoma antigen levels in invasive cervical cancer: prediction of response and recurrence.
Rose PG; Baker S; Fournier L; Nelson BE; Hunter RE
Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):942-6. PubMed ID: 8456907
[TBL] [Abstract][Full Text] [Related]
54. SCC antigen in malignant and nonmalignant squamous lesions.
Torre GC
Tumour Biol; 1998; 19(6):517-26. PubMed ID: 9817981
[TBL] [Abstract][Full Text] [Related]
55. [Basic and clinical evaluation of a new assay procedure "SCC RIABEAD" for estimation of squamous cell carcinoma related antigen].
Kuwabara Y; Ichiya Y; Komiya T; Otsuka M; Miyake Y; Takeda R; Masuda K
Radioisotopes; 1987 Oct; 36(10):534-7. PubMed ID: 3438498
[TBL] [Abstract][Full Text] [Related]
56. [Clinical evaluation of serum carbohydrate antigen 19-9 in carcinoma of the lung--a comparison with carcinoembryonic antigen].
Hayashibe A; Kodama T; Nishiwaki Y; Kudou H; Inoue Y; Nukariya N; Kaguraoka H; Kuroki M; Takahashi K; Nishiyama Y
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):711-5. PubMed ID: 3030198
[TBL] [Abstract][Full Text] [Related]
57. Value of tumor-antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancer.
Kato H; Morioka H; Tsutsui H; Aramaki S; Torigoe T
Cancer; 1982 Oct; 50(7):1294-6. PubMed ID: 7104971
[TBL] [Abstract][Full Text] [Related]
58. Squamous cell carcinoma radioimmunoassay in squamous cell carcinoma of the head and neck.
Cook DW; Winek T; Baker H; Deveney CW; Sasaki T
Am J Surg; 1989 May; 157(5):503-4. PubMed ID: 2712209
[TBL] [Abstract][Full Text] [Related]
59. Altered antigen expression predicts outcome in squamous cell carcinoma of the head and neck.
Wolf GT; Carey TE; Schmaltz SP; McClatchey KD; Poore J; Glaser L; Hayashida DJ; Hsu S
J Natl Cancer Inst; 1990 Oct; 82(19):1566-72. PubMed ID: 2119437
[TBL] [Abstract][Full Text] [Related]
60. [Tumor antigen TA-4 of squamous cell carcinoma in patients with cervical cancer].
Kato H; Morioka H; Aramaki S; Tamai K; Nagaya T; Nagai M; Torigoe T
Gan No Rinsho; 1984 May; 30(6 Suppl):574-7. PubMed ID: 6748228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]